What Is Osteomyelitis?

Osteomyelitis is an infection of bone — a serious condition that can cause permanent bone destruction, joint damage, and life-threatening systemic infection if not recognized and treated promptly. In the foot, osteomyelitis most commonly develops as a complication of diabetic foot ulcers, open fractures, surgical site infections, or penetrating trauma. It can also spread to bone from adjacent soft tissue infections (contiguous focus osteomyelitis) or via the bloodstream (hematogenous osteomyelitis), though the hematogenous route is less common in adults.

At Balance Foot & Ankle, osteomyelitis evaluation and management is an important part of our diabetic foot and wound care services. Timely diagnosis — and the distinction between osteomyelitis and adjacent soft tissue infection — directly determines treatment approach and outcomes.

Who Is at Risk for Foot Osteomyelitis?

Diabetic patients with peripheral neuropathy and foot ulcers are by far the highest-risk group for foot osteomyelitis. The combination of impaired immune function from hyperglycemia, reduced vascular supply that limits antibiotic delivery to infected tissue, and loss of protective sensation that allows ulcers to progress undetected creates ideal conditions for bone infection. It is estimated that osteomyelitis is present in 20 percent of diabetic foot infections classified as moderate severity and in up to 60 percent of severe diabetic foot infections requiring hospitalization.

Other risk factors include open fractures with exposed bone, postoperative surgical site infections, penetrating wounds from nails or glass that reach bone, and immunocompromising conditions including HIV infection, chronic steroid use, and hematologic malignancy.

Symptoms and Clinical Presentation

Foot osteomyelitis may be surprisingly subtle, particularly in neuropathic diabetic patients who cannot feel pain. The classic presentation is a non-healing diabetic foot ulcer with surrounding redness, warmth, swelling, and wound drainage. Probing the base of the wound with a sterile blunt metal probe and reaching bone — the probe-to-bone test — is approximately 80 percent specific for osteomyelitis when positive. Systemic symptoms including fever, chills, and elevated inflammatory markers suggest more severe infection, though diabetic patients with severe foot osteomyelitis may remain afebrile due to impaired immune response.

Diagnosis

Plain X-rays are obtained initially but are relatively insensitive for early osteomyelitis — bone destruction must exceed 30 to 50 percent before X-ray findings appear, typically requiring two to three weeks of infection. MRI is the gold standard imaging modality for diagnosing foot osteomyelitis, demonstrating bone marrow edema and signal changes within days of infection onset with sensitivity and specificity each exceeding 80 percent. Bone scintigraphy (three-phase bone scan) is more sensitive than X-ray but less specific than MRI, limiting its utility when MRI is available.

Tissue culture — obtained from deep wound biopsy or bone biopsy — is essential to identify the causative organisms and antibiotic sensitivities. Staphylococcus aureus (including MRSA) is the most common organism. Diabetic foot osteomyelitis is frequently polymicrobial, with additional gram-negative and anaerobic organisms present. Blood cultures should be obtained when systemic infection is suspected. Inflammatory markers including ESR, CRP, and procalcitonin support diagnosis and are used to monitor treatment response.

Treatment

Antibiotic Therapy

Antibiotic treatment is the cornerstone of osteomyelitis management. Duration is typically four to six weeks for hematogenous or contiguous-focus osteomyelitis when bone has been surgically debrided, and potentially longer for chronic osteomyelitis or when surgical debridement is not performed. Antibiotic selection is guided by culture and sensitivity results. IV antibiotics are used initially for severe infections, with transition to oral antibiotics once the patient is clinically improving and an appropriate oral agent with good bone penetration is available. Highly bioavailable oral agents including fluoroquinolones, linezolid, and clindamycin achieve bone concentrations comparable to IV therapy for many organisms.

Surgical Treatment

Surgical debridement of infected and necrotic bone is often required to achieve cure. The presence of dead bone (sequestrum) and surrounding reactive bone (involucrum) in chronic osteomyelitis creates a protected environment for bacteria that cannot be adequately penetrated by antibiotics alone. Resection of infected bone while preserving sufficient foot architecture to allow continued weight bearing requires careful surgical planning. In some cases — particularly when infection involves the entire forefoot — partial foot amputation provides the most reliable route to complete infection eradication and functional weight bearing.

The decision between antibiotic-only treatment and surgical debridement is individualized based on the extent of bone involvement, vascular supply, patient overall health and surgical risk, and realistic expectations about the feasibility of achieving cure with antibiotics alone. We coordinate closely with infectious disease specialists and vascular surgeons when surgical management of foot osteomyelitis is planned.

Ready to Relieve Your Foot Pain?

Board-certified podiatrists serving Southeast Michigan. Same-week appointments available.

Book Your Appointment

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.